Preterm Birth and Biomarkers for Cardiovascular Disease

NCT05693285 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2023-01-26

No results posted yet for this study

Summary

Preterm birth is associated with maternal increased risk of cardiovascular disease later in life. In an observational case- control study, investigators want to evaluate whether women with preterm birth have increased levels of biomarkers for cardiovascular disease, to reveal potential pathophysiological mechanisms in common.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Christina Christersson · Uppsala University

Eligibility

Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-14
Primary Completion
2022-12-02
Completion
2022-12-02

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05693285 on ClinicalTrials.gov